Public Health

Is This Namibia's Path to Universal Healthcare?
Clinical & Pharma Is This Namibia's Path to Universal Healthcare?

The Namibian government is moving forward with a transformative healthcare reform, presenting a Universal Health Coverage (UHC) bill that aims to bridge the significant gap between the nation's public and private health sectors. The Ministry of Health and Social Services has initiated a crucial

Is Policy Ignoring the Long-Term Risks of COVID?
Clinical & Pharma Is Policy Ignoring the Long-Term Risks of COVID?

While the acute phase of the global health crisis has subsided from public consciousness, a far more insidious threat continues to unfold with profound implications for millions worldwide. Years after the initial outbreak, society has largely moved on, adopting a narrative of endemic coexistence

Why Is AstraZeneca Betting $15 Billion on China?
Clinical & Pharma Why Is AstraZeneca Betting $15 Billion on China?

In a move that reverberates across the global pharmaceutical landscape, AstraZeneca has committed to a monumental $15 billion long-term investment in China, signaling a profound strategic alignment with the nation's rapidly ascending role as a biopharmaceutical powerhouse. This massive financial

How Epidemiology Pinpoints Contaminated Food
Clinical & Pharma How Epidemiology Pinpoints Contaminated Food

When a foodborne illness outbreak quietly begins, it doesn't announce itself with a single, dramatic event but rather as a series of disconnected and unfortunate incidents—a person in one state, a family in another, all suffering from the same severe symptoms. For public health officials, these

HIV Pioneer Myron Cohen to Step Down as IGHID Director
Clinical & Pharma HIV Pioneer Myron Cohen to Step Down as IGHID Director

A monumental shift in leadership is set for this June, as Dr. Myron (Mike) Cohen, a towering figure in infectious disease research and the founding director of the Institute for Global Health and Infectious Diseases (IGHID), has announced he will be stepping down from his role. This transition

Can New Leadership at Yale Reverse a Health Crisis?
Clinical & Pharma Can New Leadership at Yale Reverse a Health Crisis?

As the United States confronts a deeply concerning decline in national life expectancy driven by the relentless spread of chronic diseases, the Yale School of Public Health has made a pivotal leadership appointment aimed directly at the heart of this crisis. The selection of Dr. Magdalena Cerdá, a

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later